Disease/Infection News

RSS

Bedfont® Scientific strengthens its commitment to respiratory clinical research

Bedfont® Scientific Limited, a world leader in breath analysis with 50 years of experience manufacturing medical devices, has quietly supported respiratory research around the world and is set to make its debut at its first clinical trial-focused event in November, taking the next step toward a dedicated focus on supporting clinical trials and clinical research teams, marking the beginning of a new chapter at Bedfont®.

From NObreath 29 Oct 2026

Mosquito bite prevention helps protect children from West Nile virus

In warm climates like Southern California, multiple species of mosquitoes can bite year-round. While telltale red, itchy bumps are the most common side effect of mosquito bites, these pests can also pass diseases, like West Nile virus, on to humans.

28 Oct 2026

Canada's measles outbreak exposes vulnerabilities in disease elimination efforts

The outbreak that contributed to Canada losing its measles elimination status in November 2025 was concentrated in historically under-vaccinated communities with close social networks across Canada, the US, Mexico, and beyond, creating opportunities for cross-border transmission, concludes a study published by The BMJ today.

28 Oct 2026

Human challenge study reveals how preexisting immunity affects dengue

Dengue virus is especially pernicious compared with many other viruses, as secondary infections can actually be worse than the first one.

28 Oct 2026

Bagged salad sales plunge as Cyclospora concern grows online

This year, the U.S. saw its highest annual count of confirmed Cyclospora cases, roughly 20,000, according to the CDC.

28 Oct 2026

Opioid drop drives decline in drug-related heart infection hospitalizations

A new national study found that hospitalizations for serious heart infections associated with drug use are declining after years of increases, driven largely by a decrease in opioid-associated cases.

27 Oct 2026

NEC contributes to AI powered vaccine design through the EU funded PREPAIR VAC pandemic preparedness project

NEC Corporation today announced its participation in PREPAIR VAC, a Horizon Europe–funded research project aimed at strengthening pandemic preparedness through the application of artificial intelligence (AI) in vaccine design.

27 Oct 2026

Health experts urge annual flu vaccination ahead of holiday travel

The 2026–27 flu season is off to an early start, with influenza activity increasing earlier than typically observed and the highest activity currently reported along the West Coast, according to the Centers for Disease Control and Prevention.

27 Oct 2026

Marine-derived compound shows promise against deadly brain eating amoeba

Primary amoebic meningoencephalitis (PAM), a parasitic disease that causes the rapid deterioration of brain tissue, is one of the most lethal infections known, with a fatality rate exceeding 97%.

26 Oct 2026

African health experts urge immediate action over new Ebola cases

African health experts have called for an immediate and coordinated response from pan-African authorities after new cases of the Bundibugyo Ebola virus emerged in Kenya and Nigeria.

26 Oct 2026

New poll shows which childhood vaccines US parents trust

While support for childhood vaccines is high, concerns about COVID-19 vaccine safety during pregnancy reveal significant public health messaging challenges.

26 Oct 2026

ECDC urges preparedness as Ebola cases emerge in Africa

With cases of Ebola disease caused by Bundibugyo virus recently detected in Kenya and Nigeria, in a new report published today the European Center for Disease Prevention and Control (ECDC) reiterates the low risk for Europe while highlighting the need for preparedness.

23 Oct 2026

Better engineering of hospital handbasins could prevent superbug outbreaks

Handbasins help prevent infections in hospitals but new research from Flinders University warns that contaminated basins in healthcare might put patients at risk and have implications in outbreaks of superbugs.

23 Oct 2026

Scientists studied one million immune cells and found clues to future disease risk

Researchers developed a single-cell atlas of one million human neutrophils, identifying distinct immune cell populations and gene-expression patterns across tissues, infections, cancer, and other health conditions. Certain neutrophil signatures were associated with metabolic dysfunction, cancer outcomes, and mortality, while higher routine neutrophil counts, even within the normal range, were linked to an increased risk of chronic disease.

22 Oct 2026

Clinical trial establishes effective HIV dosing regimen for full-term newborns

An international study conducted through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network including researchers at the University of California San Diego helped inform the U.S. Food and Drug Administration's (FDA) recent approval of dolutegravir, a second-generation integrase inhibitor, for the treatment of human immunodeficiency virus (HIV-1) in newborns from birth.

22 Oct 2026

Large-scale meteorological patterns linked to Ebola virus outbreaks

A study led by the University of Malaga has shown that outbreaks of Ebola virus do not occur randomly over time; rather, their appearance is linked to specific large-scale meteorological patterns, even with oscillations occurring in regions thousands of miles away from Central Africa, where they are currently suffering from an epidemic of this disease, which can be fatal.

22 Oct 2026

Destruction of water systems directly threatens global public health

Water scarcity seldom starts wars, but wars increasingly degrade vital water systems on which health and recovery depend, creating a cycle that reinforces ongoing fragility and violence, warn experts in The BMJ's climate issue today.

22 Oct 2026

Global vaccine equity rules could save millions in future pandemics

Beginning the global COVID-19 vaccine roll-out 100 days after the virus was sequenced could have saved more than 8 million lives by the end of 2021, most of them in lower-middle-income countries, according to modelling evidence brought together in a new Policy Brief from the United Nations University Institute for Water, Environment and Health (UNU-INWEH).

22 Oct 2026

Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature Communications

Modus Therapeutics Holding AB (publ) announces that the manuscript based on the Phase Ib study SEVUSMART in severe malaria, lead-authored by Professor Kathryn Maitland of Imperial College London with co-authors from the SMAART consortium including members such as University College London and the University of Oxford, has been published today in the peer-reviewed journal Nature Communications, following independent peer review.

22 Oct 2026

Needle-free mRNA vaccines protect mice against COVID-19 and flu

A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.

22 Oct 2026